University of Texas Health Science Center
Houston, Texas, 77225, United States
NCT Number: NCT00000304
The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in cocaine treatment; an evaluation of the ""replacement"" strategy.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Phase 2
Houston, Texas, 77225, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Please contact site for information.
15 mg for first 8 weeks and 30 mg for 2nd 8 weeks
30 mg for the first 8 weeks and 60 for the second 8 weeks (16 weeks total)
Placebo
Time frame: 16 weeks of study
National Institute on Drug Abuse (NIDA)
Nih
Dextroamphetamine as an Adjunct in Cocaine Treatment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00232336
Behavior, Behavior, Addictive
Tacoma, Washington, United States
View Trial DetailsNCT00000216
Chemically-Induced Disorders, Cocaine-Related Disorders
New Haven, Connecticut, United States
View Trial DetailsNCT00000311
Chemically-Induced Disorders, Cocaine-Related Disorders
New Haven, Connecticut, United States
View Trial DetailsNCT00000271
Behavior, Behavioral Symptoms
New York, United States
View Trial Details